Cutaneous T-cell lymphoma and cutaneous graft-versus-host disease. Two indications for photopheresis in dermatology.
Dermatologists are frequently involved in the management of cutaneous T-cell lymphoma (CTCL) and graft-versus-host disease (GVHD). The similarities of these two entities are reviewed in the context of clinical and histologic findings, pathogenesis, and therapy. Photopheresis therapy (extracorporeal photochemotherapy) is used in the treatment of both entities, and the mechanisms underlying the responses represent yet another striking similarity of these two crippling dermatologic diseases.
Girardi
M
M
Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut, USA.
Heald
P W
PW
D006086:Graft vs Host Disease / Q000473:pathology / Q000628:therapy*; D006801:Humans; D016410:Lymphoma, T-Cell, Cutaneous / Q000473:pathology / Q000628:therapy*; D017893:Photopheresis; D012878:Skin Neoplasms / Q000473:pathology / Q000628:therapy*